US Patent 7893093 Sulfonyl containing compounds as cysteine protease inhibitors
Patent 7893093 was granted and assigned to Virobay on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+349 characters)
Article
Patent abstract
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Craig J. Mossman0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07893093 Sulfonyl containing compounds as cysteine protease inhibitors US Patent 7893093 Sulfonyl containing compounds as cysteine protease inhibitors
Infobox
Patent Number
07893093
Patent Number
7893093
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07893093 Sulfonyl containing compounds as cysteine protease inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07893093
Date of patent
February 22, 2011
Patent application number
11909053
Date Filed
March 22, 2006
Patent primary examiner
Find more entities like US Patent 7893093 Sulfonyl containing compounds as cysteine protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.